Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series

BACKGROUND: Chorea in Huntington's Disease (HD) is usually treated with antidopaminergic neuroleptics like haloperidol, olanzapine and tiaprid or dopamine depleting drugs like tetrabenazine. Some patients with hyperkinesia, however, react to treatment with antidopaminergic drugs by developing e...

Descripción completa

Detalles Bibliográficos
Autores principales: Saft, Carsten, Lauter, Thorsten, Kraus, Peter H, Przuntek, Horst, Andrich, Juergen E
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1413552/
https://www.ncbi.nlm.nih.gov/pubmed/16507108
http://dx.doi.org/10.1186/1471-2377-6-11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1413552/
https://www.ncbi.nlm.nih.gov/pubmed/16507108
http://dx.doi.org/10.1186/1471-2377-6-11

Ejemplares similares